The Pearson Center for Research on Alcoholism and Addiction was established at the Scripps Research Institute
On Dec. 15, 2003, the Pearson Center for Research on Alcoholism and Addiction was established at the Scripps…
On Dec. 15, 2003, the Pearson Center for Research on Alcoholism and Addiction was established at the Scripps…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Oct. 8, 2003, an obesity working group was established by the Commissioner of Food and Drugs, charged…
On Oct. 6, 2003, American chemist Paul Lauterbur and British physicist Peter Mansfield made pioneering contributions during the…
On Sept. 29, 2003, Winship Cancer Institute (WCI) at Emory University received a $1.9 million National Cancer Institute…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…
On Apr. 24, 2003, the National Cancer Institute, CDC, AHRQ, and SAMHSA, in collaboration with the American Cancer…
On April 23, 2003, Dr. Vincent Poitout at the Pacific Northwest Research Foundation won the Thomas R. Lee…
On Apr. 14, 2003, The International Human Genome Sequencing Consortium, led in the U.S. the National Human Genome…
In Sept. 2003, Emory’s Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility, adding new research and high-tech…
In Jan. 2003, the Arizona Nanotechnology Cluster, an Arizona not-for-profit organization, was formed to share technological advances, and…
In 2003, the U.S. Environmental Protection Agency (EPA) approved the first transgenic rootworm-resistant corn developed by Monsanto under…
In 2003, The Animal Drug User Fee Act permits FDA to collect subsidies for the review of certain…
In 2003, the Colorado BioScience Association (CSBA) was founded ais an independent non-profit 501(c) 6, member-funded organization. The…
In 2003, Yale Cancer Center partnered with the National Cancer Institute to create the first cooperative training program…
In 2003, over 1,000 of NNMC’s medical staff members deployed on the USNS COMFORT serving in the Persian…
On Dec. 24, 2002, the FDA’s Office of Combination Products was formed within the Office of the Commissioner,…
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
On Oct. 26, 2002, under the Medical Device User Fee and Modernization Act, fees are assessed sponsors of…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
On Aug. 21, 2002, the FDA announced an initiative to modernize the regulation of pharmaceutical manufacturing and product…
On Aug. 21, 2002, the FDA announced an effort to enhance and update the regulation of manufacturing processes…
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the Centers…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…